The Hayward-based generic drug maker (NASDAQ: IPXL) will pay Koch more than $1.15 million cash in equal installments over 12 months, according to a Securities and Exchange Commission filing Wednesday, as well as a lump sum cash payment of his pro rata target bonus for fiscal 2012 by March 15, 2013.
No comments:
Post a Comment